[1]
S. Stropuvienė, A. Baranauskaitė, L. Bukauskienė, and J. Zaikauskienė, “The impact of anti-cyclic citrullinated peptide antibody status on the management of patients with early rheumatoid arthritis: observational study results from Lithuania”, AML, vol. 25, no. 2, pp. 112–123, Aug. 2018, doi: 10.6001/actamedica.v25i2.3765.